The global dermatological therapeutics market size is projected to expand at a significant CAGR during the forecast period,2021–2028. The growth of the market is attributed to increasing aging population, rising prevalence of skin diseases, and increasing disposable income in developing countries.
Dermatology is a field of medicine that specializes in the diagnosis, prevention, and treatment of various conditions related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatological products, are applied topically to the skin. In addition, these drugs are used to treat various skin conditions such as acne, dermatitis, psoriasis, eczema, and acne.
The Covid-19 pandemic affected the demand and supply of global dermatological therapeutics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
The report on the global dermatological therapeutics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Dermatological Therapeutics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, and Others), and Drugs Class (Anti-infective, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoid, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Almirall SA; Amgen Inc.; Novartis AG; Bausch Health Companies Inc.; and AbbVie Inc. |
In terms of applications, the dermatological therapeutic market is divided into alopecia, herpes, psoriasis, rosacea, atopic dermatitis, and others. The psoriasis segment is expected to represent a key share of the market during the forecast period. Psoriasis is a chronic autoimmune skin disease that accelerates the growth cycle of skin cells and causes thick red and silvery patches of skin on the elbows, face, palms, knees, scalp, lower back, and soles of the feet. The most common form of psoriasis is plaque psoriasis, which is caused by an abnormal attack by the T cells of the skin.
Based on drug class, the dermatological therapeutics market is segregated into anti-infective, corticosteroids, anti-acne, calcineurin inhibitors, retinoid, and others. The retinoid segment is expected to hold a key share of the market in the coming years. Retinoid are a type of vitamin A derivative that has been used in skin care since the 1970s. It plays an important role in acne treatment by targeting primary microscopic lesions. They also treat oil production by slowing the growth of bacteria that cause acne and inflammation.
On the other hand, the corticosteroids segment is anticipated to expand at a rapid pace during the forecast period. Corticosteroids are known as a cortisone-like drug that is used as a pain reliever to reduce inflammation in the body. These medicines are known to have effects such as reducing itching, swelling, allergic reactions and redness.
On the basis of regions, the dermatological therapeutics market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to rising healthcare spending, growing awareness of skin diseases, and a strong presence of pharmaceutical companies.
The global dermatological therapeutics market has been segmented on the basis of
Key players competing in the dermatological therapeutics market include Almirall SA; Amgen Inc.; Novartis AG; Bausch Health Companies Inc.; and AbbVie Inc. Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.
The global dermatological therapeutics market has been segmented on the basis of
Key players competing in the dermatological therapeutics market include Almirall SA; Amgen Inc.; Novartis AG; Bausch Health Companies Inc.; and AbbVie Inc. Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.
Some other reports from this category!